TY - JOUR
T1 - “I Can’t Take off My Shirt or Do My Own Hair”—A Qualitative Investigation of the Symptoms and Impact Experience of Children and Adolescents with Fibrodysplasia Ossificans Progressiva (FOP)
AU - Markowitz, Jessica T.
AU - Rofail, Diana
AU - Vandenberg, Gerrit
AU - Baldasaro, Jessica
AU - Sanchez, Robert J.
AU - Pignolo, Robert J.
AU - Keen, Richard
AU - Davis, Michelle
AU - Marquis, Patrick
N1 - Funding Information:
This study and Rapid Service Fee were funded by Regeneron. Editorial assistance was provided by Lori Bacarella of Modus Outcomes. All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work, and have given their approval for this version to be published. All authors read and approved the final manuscript. JTM, GV, and JB contributed to research design, interview conduct, qualitative data analysis, interpretation, and manuscript development. PM contributed to research design, qualitative analysis, interpretation, and manuscript development. RS, DR, RP, RK, and MD contributed to manuscript development. Michelle Davis is a member of the Rare Bone Disease Alliance Steering Committee and the Global Genes RARE Global Advocacy Leadership Council, and the Executive Director of IFOPA. Robert J. Sanchez is an employee of Regeneron and received stock and stock options as part of his compensation. Diana Rofail is an employee of Regeneron and received stock and stock options as part of her compensation. Richard Keen is PI on the Regeneron LUMINA-1 clinical trial and Clementia/Ipsen MOVE trial, nonpaid member of the International Clinical Council on FOP and IFOPA registry advisory board. Robert J. Pignolo is PI on the Regeneron LUMINA-1 clinical trial and Clementia/Ipsen MOVE clinical trial, founding member and current president of the International Clinical Council on FOP. Modus Authors were compensated by Regeneron Pharmaceuticals, Inc. for writing this manuscript. Study documents, including the protocol, demographic and health information form, interview guide, screener, and informed consent and assent forms received ethical approval from Advarra IRB (IRB #00,046,227). This study was performed in accordance with the Helsinki Declaration of 1964 and its later amendments. All participants provided informed consent to participate in the study. Consent and assent via written consent forms were obtained from both patients and their parents before proceeding with the interviews. All data generated or analyzed during this study are included in this published article.
Publisher Copyright:
© 2022, The Author(s).
PY - 2022/6
Y1 - 2022/6
N2 - Introduction: Fibrodysplasia ossificans progressiva (FOP) is an ultra-rare, severely disabling, autosomal dominant, congenital disease characterized by progressive multi-focal heterotopic ossification (HO) of skeletal muscle, ligaments, tendons, and fascia. Past FOP studies have focused on the clinical aspects of the disease; therefore, there is a paucity of qualitative research on the patient experience. Our objective was to better understand the experience of children and adolescents living with FOP from their and their parents’ perspectives. Methods: We conducted a qualitative research study comprising in-depth, open-ended interviews with children and adolescents with FOP and their parents. Semi-structured interviews were conducted via phone call or Microsoft Teams with parent-child dyads (n = 11), adolescents (n = 6), and two clinicians. Children/adolescents and their parents were asked open-ended questions to elicit their daily experience of FOP. Results: Concepts were organized into two major themes: symptoms of FOP and the impact of FOP on daily life. Symptoms of FOP reported by children/adolescents, parents, and clinicians were pain, swelling, redness, and stiffness. Functional impacts of flares and FOP in general included accommodations, mobility, activities of daily living, daily activities, and social activities. Impacts were attributed to the difficulties children and adolescents faced living with a disease that prohibited common activities. Conclusions: This research documented the experience of children and adolescents with FOP and its effects on their daily lives. It provides a conceptual model for further exploration of the symptoms and impacts important to children and adolescents with FOP and their parents. Children and adolescents and their parents offered novel insights into life with the disease that have not previously been discussed in published literature. Future studies should build upon our conceptual model to create a holistic view of the patient experience of FOP, to inform clinical practice, and the assessment of the patient experience in clinical trials for the disease.
AB - Introduction: Fibrodysplasia ossificans progressiva (FOP) is an ultra-rare, severely disabling, autosomal dominant, congenital disease characterized by progressive multi-focal heterotopic ossification (HO) of skeletal muscle, ligaments, tendons, and fascia. Past FOP studies have focused on the clinical aspects of the disease; therefore, there is a paucity of qualitative research on the patient experience. Our objective was to better understand the experience of children and adolescents living with FOP from their and their parents’ perspectives. Methods: We conducted a qualitative research study comprising in-depth, open-ended interviews with children and adolescents with FOP and their parents. Semi-structured interviews were conducted via phone call or Microsoft Teams with parent-child dyads (n = 11), adolescents (n = 6), and two clinicians. Children/adolescents and their parents were asked open-ended questions to elicit their daily experience of FOP. Results: Concepts were organized into two major themes: symptoms of FOP and the impact of FOP on daily life. Symptoms of FOP reported by children/adolescents, parents, and clinicians were pain, swelling, redness, and stiffness. Functional impacts of flares and FOP in general included accommodations, mobility, activities of daily living, daily activities, and social activities. Impacts were attributed to the difficulties children and adolescents faced living with a disease that prohibited common activities. Conclusions: This research documented the experience of children and adolescents with FOP and its effects on their daily lives. It provides a conceptual model for further exploration of the symptoms and impacts important to children and adolescents with FOP and their parents. Children and adolescents and their parents offered novel insights into life with the disease that have not previously been discussed in published literature. Future studies should build upon our conceptual model to create a holistic view of the patient experience of FOP, to inform clinical practice, and the assessment of the patient experience in clinical trials for the disease.
KW - Children and adolescents
KW - Fibrodysplasia ossificans progressiva
KW - Patient-reported experience
KW - Qualitative research
UR - http://www.scopus.com/inward/record.url?scp=85128214440&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85128214440&partnerID=8YFLogxK
U2 - 10.1007/s12325-022-02096-3
DO - 10.1007/s12325-022-02096-3
M3 - Article
C2 - 35429282
AN - SCOPUS:85128214440
SN - 0741-238X
VL - 39
SP - 2796
EP - 2805
JO - Advances in Therapy
JF - Advances in Therapy
IS - 6
ER -